Vytronus, Inc.

Vytronus, Inc. is a medical technology company based in Sunnyvale, California, founded in 2006. The company specializes in developing innovative cardiac medical devices that use ultrasound energy to treat cardiac arrhythmias, particularly atrial fibrillation. Vytronus aims to enhance cardiac ablation procedures by utilizing collimated ultrasound as a dual-purpose energy source for imaging and ablation, which can lead to more predictable treatment outcomes. The core technology of Vytronus integrates ultrasound imaging and therapy into a single platform, designed to simplify complex cardiac procedures while prioritizing patient safety and treatment efficacy. The company focuses on making these procedures more accessible and reliable for healthcare providers and their patients. Vytronus has raised approximately $39.8 million in funding and is working towards obtaining regulatory approvals to bring its products to market.

• Employees 8
• Founded 2006
• Annual Revenue $18000000
• Total Funding $112572963